Top compounds associated with response to LCE1B


Feature Type Standardized
Nominal ANOVA
mRNA GDC-0879 CTRPv2 pan-cancer AAC 0.082 0.02
mRNA PD-0332991 CCLE pan-cancer AAC 0.11 0.02
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.03
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.03
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.078 0.03
mRNA austocystin d CTRPv2 pan-cancer AAC 0.081 0.03
mRNA T0901317 GDSC1000 pan-cancer AAC -0.073 0.03
mRNA IU1 CTRPv2 pan-cancer AAC 0.083 0.03
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.076 0.03
mRNA necrostatin-1 CTRPv2 pan-cancer AAC 0.078 0.03
Download CSV